Market Overview:
Automated patch clamp (APC) systems are electrophysiology tools used to study voltage-gated ion channels by reproducing electrophysiology techniques and measurements otherwise performed manually using a patch clamp amplifier. APC systems automate the steps required for patch clamp recordings, including contacting cells, achieving gigaseal formation, and voltage clamping. This high throughput method allows researchers to screen hundreds of compounds in a fraction of the time required for manual patch clamping. Automated patch clamp systems find wide application in drug discovery processes for ion channel drug screening, toxicology testing, and cardiac safety profiling. The need to develop therapeutic options to target the dysfunction of ion channels involved in several diseases drives demand for these systems.
Market Key Trends:
One of the key trends in the automated patch clamp system market is the development of miniaturized systems for high throughput screening. Major players are focusing on developing compact benchtop systems capable of screening hundreds to thousands of compounds per day. For instance, Nanion Technologies GmbH offers SyncroPatch 384PE and SyncroPatch 96X instruments featuring mini well-style layouts compatible with standard microplates for running multiple assays simultaneously. Moreover, continued technological advancements aim to improve efficiency, throughput, and data quality. Integrating automated patch clamp systems with liquid handling robots and artificial intelligence is also gaining traction to enable fully automated screening of massive chemical libraries. This contributes to accelerated drug discovery while lowering costs.
Porter’s Analysis
The threat of new entrants: The threat of new entrants is low due to high capital requirements for R&D, manufacturing and distribution. Bargaining power of buyers: The bargaining power of buyers is medium as there are several key players operating in the market providing a variety of options to buyers. Bargaining power of suppliers: The bargaining power of suppliers is low due to availability of substitute components from different suppliers. Threat of new substitutes: The threat of new substitutes is high as research is continuously being done to develop novel techniques for ion channel screening. Competitive rivalry: intense.
The global Automated Patch Clamp System Market Size is estimated to be valued at US$ 412.01 Mn in 2023 and is expected to exhibit a CAGR of 6.9% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Key Takeaways
The global Automated Patch Clamp System market is expected to witness high growth, exhibiting CAGR of 6.9% over the forecast period, due to increasing investments in drug discovery and rising demand for automated electrophysiology techniques for ion channel screening.
Regional Analysis
The North America region currently dominates the Automated Patch Clamp System market owing to presence of major players and huge investments for development of novel drugs in the region. Asia Pacific region is expected to witness fastest growth over the forecast period attributed to increasing outsourcing of drug development activities in countries like China and India.
Key players
Key players operating in the Automated Patch Clamp System market include Sophion Bioscience A/S, Nanion Technologies GmbH, NeoBiosystems, Inc., Multi Channel Systems MCS GmbH, Fluxion Biosciences, Molecular Devices, LLC, Scitech Korea Inc., and HEKA Elektronik GmbH. Sophion Bioscience A/S holds leading position in the global market due to its extensive product portfolio of Patch Clamp systems used for drug screening applications.
*Note:
- Source: Coherent Market Insights, Public sources, Desk research
- We have leveraged AI tools to mine information and compile it